This study followed early stage schizophrenia patients undergoing treatment with single voxel MRS in the frontal lobe. Patients were split into a placebo (sugar pills) and treatment (N-acetylcysteine (NAC)) group and followed over the course of a year where they participated in 2-3 MRS scans at regular intervals. Patients show significantly elevated concentrations of Cre and Glx when compared to controls. This significance remained throughout the longitudinal study in intra- and inter-patient comparisons. This unchanged elevation of Glx and Cre contradicts the hypothesis that NAC will work to normalize these metabolite concentrations.
This abstract and the presentation materials are available to members only; a login is required.